Cancellations by sponsors

This database shows cancellations of Australian Register of Therapeutic Goods entries requested by sponsors.

Last updated

23 December 2025

Find out more at Information about cancellations requested by the sponsor - regulatory actions.

Filters applied:

2020

Clear all

6770 result(s) found, displaying 151 to 175

GO Sun Skin Support 1-A-Day Cancelled under Section 30(1)(c) of the Act

17 December 2020

Cancellation by sponsor

Requested by The Better Health Company (Australia) PTY
Hospira Doxorubicin Hydrochloride 50 mg powder for injection vial Cancelled under Section 30(1)(c) of the Act

17 December 2020

Cancellation by sponsor

Requested by Hospira Australia Pty Ltd
Hospira Doxorubicin Hydrochloride for Injection, USP 10 mg vial Cancelled under Section 30(1)(c) of the Act

17 December 2020

Cancellation by sponsor

Requested by Hospira Australia Pty Ltd
Hospira Doxorubicin Hydrochloride for Injection USP 150 mg VIAL Cancelled under Section 30(1)(c) of the Act

17 December 2020

Cancellation by sponsor

Requested by Hospira Australia Pty Ltd
Hospira Doxorubicin Hydrochloride for Injection, USP 50 mg vial Cancelled under Section 30(1)(c) of the Act

17 December 2020

Cancellation by sponsor

Requested by Hospira Australia Pty Ltd
Hospira Doxorubicin Hydrochloride10 mg powder for injection vial Cancelled under Section 30(1)(c) of the Act

17 December 2020

Cancellation by sponsor

Requested by Hospira Australia Pty Ltd
LAMISIL JOCK ITCH DERMGEL terbinafine 10mg/g tube Cancelled under Section 30(1)(c) of the Act

17 December 2020

Cancellation by sponsor

Requested by GlaxoSmithKline Consumer Healthcare Australia Pty Ltd
Life Healthcare Pty Ltd - ArmourSorb™ Neurosurgical Rayon sponges with PTFE layer and XRD thread - Sponge, neuro Cancelled under Section 41GL(d) of the Act

17 December 2020

Cancellation by sponsor

Requested by Life Healthcare Pty Ltd
Manningham Corporation Pty Ltd - Mask, surgical, single use Cancelled under Section 41GL(d) of the Act

17 December 2020

Cancellation by sponsor

Requested by Manningham Corporation Pty Ltd
NICABATE CQ MINT LOZENGE nicotine 2mg tube Cancelled under Section 30(1)(c) of the Act

17 December 2020

Cancellation by sponsor

Requested by GlaxoSmithKline Consumer Healthcare Australia Pty Ltd
NICABATE CQ MINT LOZENGE nicotine 4mg tube Cancelled under Section 30(1)(c) of the Act

17 December 2020

Cancellation by sponsor

Requested by GlaxoSmithKline Consumer Healthcare Australia Pty Ltd
NICABATE CQ MINT nicotine 2mg lozenge blister pack Cancelled under Section 30(1)(c) of the Act

17 December 2020

Cancellation by sponsor

Requested by GlaxoSmithKline Consumer Healthcare Australia Pty Ltd
NICABATE CQ MINT nicotine 4mg lozenge blister pack Cancelled under Section 30(1)(c) of the Act

17 December 2020

Cancellation by sponsor

Requested by GlaxoSmithKline Consumer Healthcare Australia Pty Ltd
NICABATE MINIS CHERRY nicotine 1.5mg lozenge tube Cancelled under Section 30(1)(c) of the Act

17 December 2020

Cancellation by sponsor

Requested by GlaxoSmithKline Consumer Healthcare Australia Pty Ltd
NICABATE MINIS CHERRY nicotine 4mg lozenge tube Cancelled under Section 30(1)(c) of the Act

17 December 2020

Cancellation by sponsor

Requested by GlaxoSmithKline Consumer Healthcare Australia Pty Ltd
NICABATE MINIS ORANGE FLAVOUR nicotine 1.5mg lozenge tube Cancelled under Section 30(1)(c) of the Act

17 December 2020

Cancellation by sponsor

Requested by GlaxoSmithKline Consumer Healthcare Australia Pty Ltd
NICABATE nicotine 14mg/24 hour transdermal drug delivery system sachet Cancelled under Section 30(1)(c) of the Act

17 December 2020

Cancellation by sponsor

Requested by GlaxoSmithKline Consumer Healthcare Australia Pty Ltd
NICABATE nicotine 21mg/24 hours transdermal drug delivery system sachet Cancelled under Section 30(1)(c) of the Act

17 December 2020

Cancellation by sponsor

Requested by GlaxoSmithKline Consumer Healthcare Australia Pty Ltd
NICABATE nicotine 7mg/24 hours transdermal drug delivery system sachet Cancelled under Section 30(1)(c) of the Act

17 December 2020

Cancellation by sponsor

Requested by GlaxoSmithKline Consumer Healthcare Australia Pty Ltd
NICABATE PRE-QUIT nicotine 21 mg/24 hours Clear Patch transdermal drug delivery sachet Cancelled under Section 30(1)(c) of the Act

17 December 2020

Cancellation by sponsor

Requested by GlaxoSmithKline Consumer Healthcare Australia Pty Ltd
NICABATE SOFT GUM MINT nicotine 2mg chewing gum blister pack Cancelled under Section 30(1)(c) of the Act

17 December 2020

Cancellation by sponsor

Requested by GlaxoSmithKline Consumer Healthcare Australia Pty Ltd
NICABATE SOFT GUM MINT nicotine 4mg chewing gum blister pack Cancelled under Section 30(1)(c) of the Act

17 December 2020

Cancellation by sponsor

Requested by GlaxoSmithKline Consumer Healthcare Australia Pty Ltd
NICABATE STRIPS MINT ORAL FILM 2.5mg nicotine soluble film sachet Cancelled under Section 30(1)(c) of the Act

17 December 2020

Cancellation by sponsor

Requested by GlaxoSmithKline Consumer Healthcare Australia Pty Ltd
Nova Pharmaceuticals Australasia Pty Ltd - Mask Cancelled under Section 41GL(d) of the Act

17 December 2020

Cancellation by sponsor

Requested by Nova Pharmaceuticals Australasia Pty Ltd
OTRIVIN SINUS RELIEF tablets blister pack Cancelled under Section 30(1)(c) of the Act

17 December 2020

Cancellation by sponsor

Requested by GlaxoSmithKline Consumer Healthcare Australia Pty Ltd

Last updated

23 December 2025

Sub menu

Product regulation

Safety and shortages

Resources and guidance

Business services

Cancellations by sponsors

Filter results

Decision type

Date of effect

GO Sun Skin Support 1-A-Day Cancelled under Section 30(1)(c) of the Act

Hospira Doxorubicin Hydrochloride 50 mg powder for injection vial Cancelled under Section 30(1)(c) of the Act

Hospira Doxorubicin Hydrochloride for Injection, USP 10 mg vial Cancelled under Section 30(1)(c) of the Act

Hospira Doxorubicin Hydrochloride for Injection USP 150 mg VIAL Cancelled under Section 30(1)(c) of the Act

Hospira Doxorubicin Hydrochloride for Injection, USP 50 mg vial Cancelled under Section 30(1)(c) of the Act

Hospira Doxorubicin Hydrochloride10 mg powder for injection vial Cancelled under Section 30(1)(c) of the Act

LAMISIL JOCK ITCH DERMGEL terbinafine 10mg/g tube Cancelled under Section 30(1)(c) of the Act

Life Healthcare Pty Ltd - ArmourSorb™ Neurosurgical Rayon sponges with PTFE layer and XRD thread - Sponge, neuro Cancelled under Section 41GL(d) of the Act

Manningham Corporation Pty Ltd - Mask, surgical, single use Cancelled under Section 41GL(d) of the Act

NICABATE CQ MINT LOZENGE nicotine 2mg tube Cancelled under Section 30(1)(c) of the Act

NICABATE CQ MINT LOZENGE nicotine 4mg tube Cancelled under Section 30(1)(c) of the Act

NICABATE CQ MINT nicotine 2mg lozenge blister pack Cancelled under Section 30(1)(c) of the Act

NICABATE CQ MINT nicotine 4mg lozenge blister pack Cancelled under Section 30(1)(c) of the Act

NICABATE MINIS CHERRY nicotine 1.5mg lozenge tube Cancelled under Section 30(1)(c) of the Act

NICABATE MINIS CHERRY nicotine 4mg lozenge tube Cancelled under Section 30(1)(c) of the Act

NICABATE MINIS ORANGE FLAVOUR nicotine 1.5mg lozenge tube Cancelled under Section 30(1)(c) of the Act

NICABATE nicotine 14mg/24 hour transdermal drug delivery system sachet Cancelled under Section 30(1)(c) of the Act

NICABATE nicotine 21mg/24 hours transdermal drug delivery system sachet Cancelled under Section 30(1)(c) of the Act

NICABATE nicotine 7mg/24 hours transdermal drug delivery system sachet Cancelled under Section 30(1)(c) of the Act

NICABATE PRE-QUIT nicotine 21 mg/24 hours Clear Patch transdermal drug delivery sachet Cancelled under Section 30(1)(c) of the Act

NICABATE SOFT GUM MINT nicotine 2mg chewing gum blister pack Cancelled under Section 30(1)(c) of the Act

NICABATE SOFT GUM MINT nicotine 4mg chewing gum blister pack Cancelled under Section 30(1)(c) of the Act

NICABATE STRIPS MINT ORAL FILM 2.5mg nicotine soluble film sachet Cancelled under Section 30(1)(c) of the Act

Nova Pharmaceuticals Australasia Pty Ltd - Mask Cancelled under Section 41GL(d) of the Act

OTRIVIN SINUS RELIEF tablets blister pack Cancelled under Section 30(1)(c) of the Act